cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Repare Therapeutics Inc
12 own
13 watching
Current Price
$1.28
$-0.03
(-2.67%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
144.84M
52-Week High
52-Week High
8.49000
52-Week Low
52-Week Low
1.20000
Average Volume
Average Volume
0.16M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization144.84M
icon52-Week High8.49000
icon52-Week Low1.20000
iconAverage Volume0.16M
iconDividend Yield--
iconP/E Ratio--
What does the Repare Therapeutics Inc do?
Repare Therapeutics Inc. is a clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. Its pipeline includes lunresertib (RP-6306), a PKMYT1 inhibitor in Phase 1/2 clinical development; camonsertib (RP-3500), a potential Ataxia-Telangiectasia and Rad3-related protein kinase (ATR) inhibitor in Phase 1/2 clinical development; RP-1664, a Phase 1 PLK4 inhibitor; RP-3467, a preclinical polymerase theta adenosinetriphosphatase (ATPase) inhibitor program, and additional, undisclosed preclinical programs. RP-3500 is a potent and selective oral small molecule inhibitor of ATR in clinical development for the treatment of solid tumors with specific DNA damage repair-related genomic alterations.
Read More
How much money does Repare Therapeutics Inc make?
News & Events about Repare Therapeutics Inc.
Ticker Report
1 year ago
Repare Therapeutics (NASDAQ:RPTX Get Rating) was upgraded by Stifel Nicolaus from a hold rating to a buy rating in a note issued to investors on Friday, The Fly reports. The brokerage currently has a $16.00 price target on the stock, up from their previous price ...
Zolmax
1 year ago
Repare Therapeutics (NASDAQ:RPTX Get Rating) had its target price upped by equities researchers at HC Wainwright from $25.00 to $26.00 in a research report issued to clients and investors on Friday, The Fly reports. HC Wainwrights price objective points to a potential upside of 116.31% from the ...
Business Wire
1 year ago
Repare Therapeutics Inc. (Repare or the Company) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today presented initial data from its ongoing Phase 1/2 TRESR clinical trial evaluating camonsertib (RP-3500/RG6526, partnered with Roche), a potent and selective oral small...
Globe Newswire
1 year ago
NEW YORK, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Repare Therapeutics Inc. (Repare or the Company) (NASDAQ: RPTX). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The ...
PR Newswire
1 year ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Repare Therapeutics Inc. - RPTX SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Repare Therapeutics Inc. - RPTX PR Newswire NEW YORK, Feb. 13, 2023 NEW YORK, Feb. 13, 2023...
Frequently Asked Questions
Frequently Asked Questions
What is Repare Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Repare Therapeutics Inc shares?
plus_minus_icon
How can I buy Repare Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Repare Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Repare Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Repare Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Repare Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Repare Therapeutics Inc?
plus_minus_icon
What percentage is Repare Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Repare Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.28
$-0.03
(-2.67%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
PULMONX CORP
PULMONX CORP
$6.84
$-0.21 (-2.98 %)
Zomedica Corp
Zomedica Corp
$0.13
$-0.00 (-1.47 %)
Sundial Growers Inc
Sundial Growers Inc
$1.80
$0.00 (0.28 %)
Mind Medicine (MindMed) Inc.
Mind Medicine (MindMed) Inc.
$6.40
$-0.09 (-1.46 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
PULMONX CORP
PULMONX CORP
$6.84
$-0.21 (-2.98 %)
Zomedica Corp
Zomedica Corp
$0.13
$-0.00 (-1.47 %)
Sundial Growers Inc
Sundial Growers Inc
$1.80
$0.00 (0.28 %)
Mind Medicine (MindMed) Inc.
Mind Medicine (MindMed) Inc.
$6.40
$-0.09 (-1.46 %)
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.

              Borderless Softtech Pvt Ltd ("BSPL") licenses and offers the Stockal Platform to subscribers and users who are based in India and wish to make global transactions. Such subscribers and users may be offered annual or monthly subscription plans by BSPL and in such cases, BSPL acts as their service provider.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00